Company Filing History:
Years Active: 2013
Title: Innovations in Medical Diagnostics: The Contributions of Wonryeon Cho
Introduction: Wonryeon Cho, an innovator based in West Lafayette, IN, has made significant strides in the field of medical diagnostics. With one patent to his name, Cho's work focuses on advancing the detection of glycopeptides and glycoproteins, which are crucial for understanding various diseases, including cancers such as malignant lymphoma and breast cancer.
Latest Patents: Cho's noteworthy patent titled "Detection of glycopeptides and glycoproteins for medical diagnostics" brings forth a diagnostic method aimed at determining the presence or absence of disease. This innovative method involves assaying the amounts and types of glycopeptides in a sample from a subject and comparing them with reference glycopeptides. The technique may also incorporate advanced methodologies like stable isotope labeling, affinity selection, and immunoaffinity chromatography, utilizing glycoproteomics techniques to identify and quantify changes associated with serious health conditions.
Career Highlights: As a member of the Purdue Research Foundation, Cho has aligned his expertise with research that propels the frontiers of medical science. His focus on glycosylated peptides and proteins is essential for monitoring patient responses to therapy and tracking disease recurrences, thereby enhancing the capabilities of modern diagnostics.
Collaborations: Throughout his career, Cho has collaborated with esteemed colleagues, including Fred E. Regnier and Stephen B. Hooser. These collaborations have provided a significant foundation for his research and have contributed to the successful development of his patent.
Conclusion: Wonryeon Cho exemplifies the spirit of innovation in medical diagnostics through his dedicated research and patented methodologies. His work not only enhances the understanding of disease markers but also improves the monitoring of treatment efficacy, ultimately benefiting patients and healthcare providers alike. As he continues at the Purdue Research Foundation, the medical community eagerly anticipates further advancements from his ongoing innovations.